Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Bolt Biotherapeutics stock have an average target of 1.00, which predicts a 241.30% increase from the current stock price of 0.29.

Price Target: $1.00 (+241.30%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.00	$1.00	$1.00	$1.00
Change	+241.30%	+241.30%	+241.30%	+241.30%

Analyst Ratings

The average analyst rating for Bolt Biotherapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	5	5	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Willey Stifel	Stifel	Hold Maintains $1.25 → $1	Hold	Maintains	$1.25 → $1	+241.30%	May 13, 2025
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 25, 2025
Stephen Willey Stifel	Stifel	Hold Maintains $1.5 → $1.25	Hold	Maintains	$1.5 → $1.25	+326.62%	Mar 25, 2025
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 13, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.90M

Decreased by -62.29%

from 7.69M

Revenue Next Year

5.15M

Increased by 77.48%

from 2.90M

EPS This Year

-1.45

from -1.65

EPS Next Year

-1.05

from -1.45

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	231.00K	1.26M	5.73M	7.88M	7.69M	2.90M	5.15M	14.00M
Revenue Growth	7.44%	445.46%	354.68%	37.48%	-2.36%	-62.29%	77.48%	172.06%
EPS	-28.89	-2.97	-2.36	-1.83	-1.65	-1.45	-1.05	-0.38
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	5.3M	15.9M	38.4M
Avg	2.9M	5.1M	14.0M
Low	n/a	n/a	196,000

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-31.2%	449.1%	646.2%
Avg	-62.3%	77.5%	172.1%
Low	-	-	-96.2%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.18	-0.59	-0.36
Avg	-1.45	-1.05	-0.38
Low	-1.81	-1.89	-0.41

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.